These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9116372)

  • 1. [Value of neo-angiogenesis evaluation in cancer of the breast].
    Namer M; Ettore R; Pivot X; Ferrero JM; Teissier E
    Bull Cancer; 1996 Dec; 83(12):1041-2. PubMed ID: 9116372
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships between different measurements of vascularity and clinico-pathological parameters in breast cancer.
    Pendleton N; Pazouki S; Heerkens E; Smither RL; Chisholm DM; Moore JV; Howell A; Horan MA; Schor AM
    Anticancer Res; 1998; 18(6B):4565-8. PubMed ID: 9891519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship of estrogen and progesterone receptors to the menstrual cycle and menopausal status at the time of breast surgery].
    Karbowski B; Jackisch C; Deppe B; Schneider HP
    Zentralbl Gynakol; 1999; 121(8):367-74. PubMed ID: 10486879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of the biochemical and histochemical determination of hormone receptors in carcinoma of the breast with the age of the patient, stage and histologic type of the neoplasm].
    Campobasso O; Concina S; Cozzani C; Ribotta M; Di Carlo F; Conti G; Racca S
    Pathologica; 1987; 79(1059-1060):53-9. PubMed ID: 3441412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
    Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
    J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors in breast cancer with contralateral supraclavicular or axillary lymphatic metastases].
    Muñoz-González D; Mora-Tizcareño A; Ramírez-Ugalde MT; Pérez-Sánchez M; Sánchez-Valdivieso E; Gómez-Ruiz C; Zeichner-Gancz I
    Rev Invest Clin; 1998; 50(1):25-30. PubMed ID: 9608786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.
    Hansen S; Grabau DA; Sørensen FB; Bak M; Vach W; Rose C
    Clin Cancer Res; 2000 Jan; 6(1):139-46. PubMed ID: 10656442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese female breast cancer patients show a better overall survival than their male counterparts.
    Xia LP; Zhou FF; Guo GF; Wang F; Wang X; Yuan ZY; Zhang B
    Chin Med J (Engl); 2010 Sep; 123(17):2347-52. PubMed ID: 21034547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between histological parameters and receptor status of tumors of the breast: analysis of a homogeneous population from Mantua].
    Dina R; Bellomi A
    Pathologica; 1987; 79(1059-1060):91-6. PubMed ID: 3441415
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies.
    Vameşu S
    Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
    Jang KS; Han HX; Paik SS; Brown PH; Kong G
    Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between morphology and steroid receptors in breast cancer].
    Hanselmann R; Genton CY
    Pathologe; 1983 Jan; 4(1):17-23. PubMed ID: 6844281
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Allevi G; Bolsi G; Aguggini S; Brunelli A; Betri E; Generali D; Scaratti L; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2002 Jun; 8(6):1816-21. PubMed ID: 12060622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen receptor and progesterone receptor as a prognostic indicator of breast cancer].
    Ikeda T; Enomoto K; Kubouchi K; Shimada M; Fujiwara K; Abe O
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):703-9. PubMed ID: 3404020
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
    Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M
    Clin Cancer Res; 2000 Feb; 6(2):452-9. PubMed ID: 10690523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital.
    Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
    Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
    Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating soluble Fas concentration in breast cancer patients.
    Ueno T; Toi M; Tominaga T
    Clin Cancer Res; 1999 Nov; 5(11):3529-33. PubMed ID: 10589768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.